- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 8 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 2 x 1K8: 3-chloranyl-2-piperazin-1-yl-quinoline(Non-covalent)
1K8.2: 14 residues within 4Å:- Chain A: L.404, D.407, D.408, V.411, I.438, A.441, L.442, I.445, A.446, L.449, K.940, L.944, E.947, F.948
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:V.411, A:I.438, A:A.441, A:I.445, A:L.944, A:E.947, A:F.948
- Hydrogen bonds: A:L.404
- Halogen bonds: A:K.940
1K8.29: 11 residues within 4Å:- Chain B: L.219, Q.228, L.230, N.231, A.232
- Chain C: P.725, M.781, P.783, W.809, Y.811
- Ligands: SO4.31
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:L.219, B:L.230, B:A.232, C:W.809
- pi-Stacking: C:W.809
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 6 residues within 4Å:- Chain A: P.50, R.185, E.273, G.755, Y.772, M.774
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.185, A:R.185
EDO.9: 5 residues within 4Å:- Chain A: D.566, E.567, D.568, K.643, S.997
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.566, A:D.568
EDO.10: 4 residues within 4Å:- Chain A: E.693, E.810
- Chain E: Y.56, F.90
5 PLIP interactions:1 interactions with chain E, 4 interactions with chain A- Hydrogen bonds: E:Y.56, A:E.693, A:E.810
- Water bridges: A:E.693, A:R.808
EDO.12: 4 residues within 4Å:- Chain A: D.99
- Chain B: I.102
- Chain C: D.99, I.102
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.99
EDO.13: 4 residues within 4Å:- Chain A: Y.811
- Chain E: E.20, R.23, D.44
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain E- Hydrogen bonds: A:Y.811, E:D.44
EDO.14: 5 residues within 4Å:- Chain A: N.231, S.233
- Chain B: S.84, T.724, P.814
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.84, B:T.724, B:T.724
EDO.19: 5 residues within 4Å:- Chain B: M.115, G.126, V.127
- Chain C: Q.112, P.116
3 PLIP interactions:1 interactions with chain C, 2 interactions with chain B- Hydrogen bonds: C:Q.112, B:V.127
- Water bridges: B:Q.112
EDO.20: 3 residues within 4Å:- Chain B: N.74, T.98, D.99
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.99
- Water bridges: B:N.74
EDO.26: 3 residues within 4Å:- Chain B: S.537, G.539, R.540
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.539, B:R.540
EDO.27: 6 residues within 4Å:- Chain B: Q.437, F.948, D.951, L.952, K.955, M.970
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:K.955, B:K.955
- Water bridges: B:R.418
EDO.33: 4 residues within 4Å:- Chain A: N.820, D.858
- Chain C: E.309, K.312
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:D.858, C:K.312
- Water bridges: A:N.820, A:N.820
EDO.41: 6 residues within 4Å:- Chain A: S.84, G.581, T.724
- Chain C: Q.218, N.231, S.233
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:G.581, A:T.724, A:T.724
- Water bridges: C:S.233, C:S.233
EDO.42: 2 residues within 4Å:- Chain C: S.46, G.126
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Q.125
EDO.43: 7 residues within 4Å:- Chain C: G.675, T.676, A.677, D.681, N.719, E.826, L.828
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:A.677, C:E.826
- 3 x OCT: N-OCTANE(Non-covalent)
OCT.5: 1 residues within 4Å:- Chain A: W.895
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.895, A:W.895
OCT.32: 1 residues within 4Å:- Chain C: W.13
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:W.13, C:W.13
OCT.35: 3 residues within 4Å:- Chain C: S.523, S.530
- Ligands: LMT.34
No protein-ligand interaction detected (PLIP)- 3 x C14: TETRADECANE(Non-covalent)
C14.6: 4 residues within 4Å:- Chain A: W.13, R.363, T.495, M.496
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:W.13
C14.8: 7 residues within 4Å:- Chain A: F.386, A.457, F.458, R.468, I.472, V.475, S.476
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:A.457, A:F.458, A:V.475
C14.37: 4 residues within 4Å:- Chain B: K.29
- Chain C: F.458, F.459, V.883
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:F.458, C:F.458, C:F.459, C:F.459, C:V.883
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 7 residues within 4Å:- Chain A: E.152, Y.182, E.269, L.270, G.271, G.272, Y.275
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:E.152, A:E.152, A:E.269, A:G.272
- Water bridges: A:E.152
GOL.15: 7 residues within 4Å:- Chain A: R.168, T.169, E.309
- Chain B: L.75, M.76, Y.77, N.820
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.168, B:L.75
- Water bridges: A:E.309, A:E.309
GOL.22: 5 residues within 4Å:- Chain B: N.189, R.263, D.264, A.266, E.776
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.189, B:R.263
GOL.24: 9 residues within 4Å:- Chain B: P.50, G.51, R.185, E.273, N.274, G.755, G.756, Y.772, M.774
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.185, B:R.185, B:G.755
- Water bridges: B:Y.275
GOL.25: 4 residues within 4Å:- Chain B: Q.210, E.245, K.248, I.249
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.245
GOL.40: 7 residues within 4Å:- Chain C: R.185, E.273, N.274, G.755, G.756, Y.772, M.774
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:R.185, C:R.185, C:G.756
- Water bridges: C:Y.275
- 1 x D10: DECANE(Non-covalent)
- 1 x DDR: (2S)-3-hydroxypropane-1,2-diyl didecanoate(Non-covalent)
- 1 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.30: 4 residues within 4Å:- Chain B: N.361, F.362, R.363, K.498
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:F.362, B:R.363
SO4.31: 5 residues within 4Å:- Chain B: Q.228, Q.229, L.230
- Chain C: L.782
- Ligands: 1K8.29
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Q.228, B:Q.229, B:L.230, B:L.230
SO4.44: 3 residues within 4Å:- Chain C: K.55, G.691, H.692
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:H.692
- Salt bridges: C:K.55
- 2 x LPX: (2S)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl hexadecanoate(Non-covalent)
LPX.36: 6 residues within 4Å:- Chain C: F.388, A.457, R.468, Q.469, S.471, I.472
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:A.457, C:I.472
- Hydrogen bonds: C:Q.469, C:S.471
- Salt bridges: C:R.468
LPX.38: 9 residues within 4Å:- Chain B: I.10, L.21
- Chain C: I.882, F.885, S.894, W.895, S.896, R.1030, F.1033
9 PLIP interactions:8 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:I.882, C:F.885, C:W.895, C:W.895, B:L.21
- Hydrogen bonds: C:W.895, C:S.896, C:S.896
- Salt bridges: C:R.1030
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ple, C. et al., Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps. Nat Commun (2022)
- Release Date
- 2021-12-29
- Peptides
- Multidrug efflux pump subunit AcrB: ABC
DARPIN: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 8 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 2 x 1K8: 3-chloranyl-2-piperazin-1-yl-quinoline(Non-covalent)
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 3 x OCT: N-OCTANE(Non-covalent)
- 3 x C14: TETRADECANE(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 1 x D10: DECANE(Non-covalent)
- 1 x DDR: (2S)-3-hydroxypropane-1,2-diyl didecanoate(Non-covalent)
- 1 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 2 x LPX: (2S)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl hexadecanoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ple, C. et al., Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps. Nat Commun (2022)
- Release Date
- 2021-12-29
- Peptides
- Multidrug efflux pump subunit AcrB: ABC
DARPIN: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.